Discover
MMED
MiniMed Group, Inc. Common Stock
16.70
5 x 16.00
1 x 19.30
bid
ask
-
0.22
1.30%
04:00 PM
| Ytd | -9.68% | |
| 1y | -9.68% |
16.68
day range
17.51
10.65
52 week range
20.48
| Open | 16.85 | Prev Close | 16.92 | Low | 16.68 | High | 17.51 | Mkt Cap | 4.69B |
| Vol | 1.13M | Avg Vol | 958.14K | EPS | -0.78 | P/E | -21.55 | Forward P/E | 22.46 |
| Beta | N/A | Short Ratio | 4.96 | Inst. Own | 12.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-17 | 50-d Avg | 13.82 | 200-d Avg | 14.19 | 1yr Est | 20.60 |
| Income Statement | |||
| Total Revenue | 837.00M | ||
| Revenues (USD) | 837.00M | ||
| Cost of Revenue | 357.00M | ||
| Gross Profit | 480.00M | ||
| Operating Expenses | 573.00M | ||
| Research and Development Expense | 99.00M | ||
| Selling, General and Administrative Expense | 299.00M | ||
| Operating Income | -93.00M | ||
| Income Tax Expense | 93.00M | ||
| Net Income | -185.00M | ||
| Net Income Common Stock | -185.00M | ||
| Net Income Common Stock (USD) | -185.00M | ||
| Consolidated Income | -185.00M | ||
| Earnings per Basic Share | -0.71 | ||
| Earnings per Basic Share (USD) | -0.71 | ||
| Earnings per Diluted Share | -0.71 | ||
| Earning Before Interest & Taxes (EBIT) | -92.00M | ||
| Earning Before Interest & Taxes (USD) | -92.00M | ||
| Weighted Average Shares | 267.96M | ||
| Weighted Average Shares Diluted | 267.96M | ||
| Balance Sheet | |||
| Cash and Equivalents | 298.00M | ||
| Cash and Equivalents (USD) | 298.00M | ||
| Trade and Non-Trade Receivables | 655.00M | ||
| Current Assets | 1.35B | ||
| Property, Plant & Equipment Net | 711.00M | ||
| Total Assets | 4.63B | ||
| Current Liabilities | 702.00M | ||
| Total Liabilities | 1.02B | ||
| Accumulated Retained Earnings (Deficit) | -116.00M | ||
| Accumulated Other Comprehensive Income | -12.00M | ||
| Shareholders Equity | 3.61B | ||
| Shareholders Equity (USD) | 3.61B | ||
| Assets Non-Current | 3.28B | ||
| Goodwill and Intangible Assets | 2.36B | ||
| Inventory | 341.00M | ||
| Liabilities Non-Current | 317.00M | ||
| Trade and Non-Trade Payables | 300.00M | ||
| Tax Assets | 61.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 39.00M | ||
| Net Cash Flow from Financing | 512.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 287.00M | ||
| Capital Expenditure | -56.00M | ||
| Issuance (Purchase) of Equity Shares | 538.00M | ||
| Net Cash Flow from Investing | -56.00M | ||
| Net Cash Flow from Operations | -170.00M | ||
| Effect of Exchange Rate Changes on Cash | 1000.00K | ||
| Share Based Compensation | 8.00M | ||